Investor Alert

London Markets Open in:

press release

March 1, 2022, 8:05 a.m. EST

BioLife Solutions to Attend and Present at Upcoming Investor Conferences

Cowen presentation is scheduled for Wednesday, March 9th from 12:50-1:30pm ET in Track 12KeyBanc presentation will be a fireside chat on Wednesday, March 23rd - tentatively scheduled for 4:30pm ET.

BOTHELL, Wash., March 1, 2022 /PRNewswire/ -- BioLife Solutions, Inc. /zigman2/quotes/207858501/composite BLFS +5.77%  ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (CGT) and the broader biopharma markets, today announced Mike Rice, Chairman and CEO, Rod de Greef, President and COO, and Troy Wichterman, CFO, are scheduled to present at both the Cowen and KeyBanc Investor Conferences in March 2022.

COWEN 42 [nd] Annual Health Care Conference (Virtual)
Track 12
Wednesday, March 9 [th] 12:50-1:20pm ET 

KeyBanc Life Sciences & MedTech Forum
Fireside Chat
Wednesday, March 23 [rd] 4:30pm ET

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary  CryoStor ® and HypoThermosol [�’] biopreservation media for shipping and storage, the ThawSTAR ® family of automated, water-free thawing products,  evo ® cold chain management system,   high capacity cryogenic storage freezersStirling Ultracold  mechanical freezers,  SciSafe  biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com , www.scisafe.com , www.stirlingultracold.com , or www.sextonbio.com  and follow BioLife on Twitter .

Media & Investor Relations

At the Company

Troy Wichterman
Chief Financial Officer
(425) 402-1400


LHA Investor Relations
Jody Cain
(310) 691-7100


View original content to download multimedia: https://www.prnewswire.com/news-releases/biolife-solutions-to-attend-and-present-at-upcoming-investor-conferences-301492598.html

SOURCE BioLife Solutions, Inc.


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

US : U.S.: Nasdaq
$ 26.01
+1.42 +5.77%
Volume: 361,039
Aug. 15, 2022 4:00p
P/E Ratio
Dividend Yield
Market Cap
$1.04 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.